These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3757408)

  • 21. Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes' Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions.
    Oshima S; Enjuji T; Negishi A; Akimoto H; Ohara K; Okita M; Numajiri S; Inoue N; Ohshima S; Terao A; Kobayashi D
    Biol Pharm Bull; 2017 Sep; 40(9):1389-1398. PubMed ID: 28579595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the Risk of Adverse Drug Reactions in Older Inpatients: External Validation of the GerontoNet ADR Risk Score Using the CRIME Cohort.
    Petrovic M; Tangiisuran B; Rajkumar C; van der Cammen T; Onder G
    Drugs Aging; 2017 Feb; 34(2):135-142. PubMed ID: 28000156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models.
    Liang Z; Liu J; Huang JX; Zeng X
    Comb Chem High Throughput Screen; 2018; 21(2):93-99. PubMed ID: 29336255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools.
    Danjuma MI; Shokri SA; Abubeker IY; Malik AE; Abdallah IMH; Shafei MNE; Fatima H; Mahmoud M; Hussain T; Maghoub Y; Sajid J; Zouki ANE
    Medicine (Baltimore); 2020 Jan; 99(1):e18569. PubMed ID: 31895800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-rater reliability of diagnostic criteria for sacroiliac joint-, disc- and facet joint pain.
    van Tilburg CWJ; Groeneweg JG; Stronks DL; Huygen FJPM
    J Back Musculoskelet Rehabil; 2017; 30(3):551-557. PubMed ID: 27858686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.
    Bouvy JC; De Bruin ML; Koopmanschap MA
    Drug Saf; 2015 May; 38(5):437-53. PubMed ID: 25822400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difficulties in assessing the adverse effects of drugs.
    Kramer MS
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):105S-110S. PubMed ID: 7052788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning model combining features from algorithms with different analytical methodologies to detect laboratory-event-related adverse drug reaction signals.
    Jeong E; Park N; Choi Y; Park RW; Yoon D
    PLoS One; 2018; 13(11):e0207749. PubMed ID: 30462745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study.
    da Costa BR; Beckett B; Diaz A; Resta NM; Johnston BC; Egger M; Jüni P; Armijo-Olivo S
    Syst Rev; 2017 Mar; 6(1):44. PubMed ID: 28253938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.
    Hwang Y; Oh M; Jang G; Lee T; Park C; Ahn J; Yoon Y
    Mol Biosyst; 2017 Aug; 13(9):1788-1796. PubMed ID: 28702565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects.
    Wang Y; Chen X; Liu L; Chen Y; Ma H; Yang R; Liu X
    Mol Biosyst; 2015 Jul; 11(7):2060-7. PubMed ID: 25992869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reactions--a computer-assisted application of correspondence analysis for automatic causality assessment.
    Bastin C; Wertheimer P; Venulet J
    Methods Inf Med; 1984 Oct; 23(4):183-8. PubMed ID: 6513792
    [No Abstract]   [Full Text] [Related]  

  • 40. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.